NASDAQ : ABVC
$0.04 (3.31%)
NASDAQ
Uttam Yashwant Patil
Biotechnology
Healthcare
ABVC
19
US
USD
0.25
0.12
0.12
0.03
0.00
-$
-22.76
2.95
-5.42
-0.13
-$0.39
-$7.91M
1183.83%
1243.11%
-92.03%
-47.75%
-10.88
0.48
0.48
1/5
1 Analysts
%
About ABVC BioPharma, Inc. (NASDAQ:ABVC) Stock
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combination treatment for triple-negative breast cancer. ABV-1504 has successfully completed Phase II clinical trials for major depressive disorders. ABV-1505 is progressing through Phase II clinical studies for attention deficit hyperactivity disorder (ADHD). ABV-1703 has concluded its Phase I clinical trials for the treatment of pancreatic cancer. ABV-1702 has also finished Phase I clinical investigations for myelodysplastic syndromes. ABV-1601 is in Ph ... ase I/II clinical trials, aimed at alleviating depression in individuals with cancer. ABV-1701 Vitargus is in development to treat conditions such as retinal detachment or vitreous hemorrhage. ABVC BioPharma maintains strategic alliances, including a co-development arrangement with Rgene Corporation, alongside collaborative agreements with BioHopeKing Corporation and BioFirst Corporation. The company's headquarters are located in Fremont, California, and it operates as a subsidiary of YuanGene Corporation.
Contrasting ABVC BioPharma (NASDAQ:ABVC) and Edgewise Therapeutics (NASDAQ:EWTX)
2026-04-27 01:12:46
ABVC BioPharma (NASDAQ: ABVC - Get Free Report) and Edgewise Therapeutics (NASDAQ: EWTX - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings. Valuation and Earnings This table compares ABVC BioPharma
ABVC BioPharma (NASDAQ:ABVC) Stock Price Down 3.4% – Time to Sell?
2026-04-24 02:20:53
ABVC BioPharma, Inc. (NASDAQ: ABVC - Get Free Report)'s stock price was down 3.4% during trading on Thursday. The stock traded as low as $1.11 and last traded at $1.14. Approximately 49,807 shares changed hands during trading, a decline of 66% from the average daily volume of 146,310 shares. The stock had previously closed at
Frequently Asked Questions
What is the current ABVC BioPharma, Inc. (ABVC) stock price?
ABVC BioPharma, Inc.(NASDAQ:ABVC) stock price is $1.25 in the last trading session. During the trading session, ABVC stock reached the peak price of $3.6 while $0.88 was the lowest point it dropped to. The percentage change in ABVC stock occurred in the recent session was 3.31% while the dollar amount for the price change in ABVC stock was $0.04.
ABVC's industry and sector of operation?
The NASDAQ listed ABVC is part of Biotechnology industry that operates in the broader Healthcare sector.
Who are the executives of ABVC?
Eugene Jiang
| Chairman & Chief Business Officer
Uttam Yashwant Patil
| Chief Executive Officer & Interim Chief Financial Officer
Tsung-Shann Jiang
| Chief Scientific Officer, Chief Strategy Officer & Director
|
|
How many employees does ABVC have?
Number of ABVC employees currently stands at 19. ABVC operates from 44370 Old Warm Springs Boulevard, Fremont, CA 94538, US.
Link for ABVC official website?
Official Website of ABVC is: https://www.abvcpharma.com
How do I contact ABVC?
ABVC could be contacted at phone #510 668 0881 and can also be accessed through its website. ABVC operates from 44370 Old Warm Springs Boulevard, Fremont, CA 94538, US.
How many shares of ABVC are traded daily?
The average number of ABVC shares traded daily for last 3 months was 138.62K.
What is the market cap of ABVC currently?
The market value of ABVC currently stands at $18.11M with its latest stock price at $1.25